share_log

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Director Sankar Shyam

SEC announcement ·  Jun 15 04:36
Summary by Futu AI
On June 12, 2024, Shyam Sankar, associated with Ginkgo Bioworks Holdings, Inc., executed a transaction involving the company's Class A Common Stock. Sankar acquired 105,263 shares through the exercise or conversion of derivative securities, as per the transaction code 'M'. Following this transaction, Sankar's direct holdings in Ginkgo Bioworks totaled 2,462,137 shares of Class A Common Stock. The transaction reflects a significant increase in Sankar's stake in the company, indicating a bolstered investment in Ginkgo Bioworks' future.
On June 12, 2024, Shyam Sankar, associated with Ginkgo Bioworks Holdings, Inc., executed a transaction involving the company's Class A Common Stock. Sankar acquired 105,263 shares through the exercise or conversion of derivative securities, as per the transaction code 'M'. Following this transaction, Sankar's direct holdings in Ginkgo Bioworks totaled 2,462,137 shares of Class A Common Stock. The transaction reflects a significant increase in Sankar's stake in the company, indicating a bolstered investment in Ginkgo Bioworks' future.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.